Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)

Authors :: Hun Lee
Ian W. Flinn
Jason Melear
Rod Ramchandren
Judah Friedman
John M. Burke
Yuliya Linhares
Paul Alan Gonzales
Mihir Raval
Rangaswamy Chintapatla
Tatyana Feldman
Habte Yimer
Miguel Islas-Ohlmayer
Asad Dean
Vishal Rana
Mitul Gandhi
John Renshaw
Linda Ho
Michelle A. Fanale
Wenchuan Guo
Christopher A. Yasenchak
Source :: Blood. 140:763-765
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools